Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listings
Events
More
Strategic Alliance Partners
Sponsored

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Subscribe
  • Strategic Alliance Partners
  • Sponsored
  • Fibromyalgia
  • Gout
  • Lupus
    • Lupus Nephritis
    • Cutaneous Lupus Erythematosus
    • Systemic Lupus Erythematosus
  • Osteoarthritis
  • Osteoporosis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Sjögren's Disease
  • Spondyloarthritis
    • Axial spondyloarthritis
    • Nonradiographic axial spondyloarthritis
Spotlight -
FDA News
Advertisement

Nicole Zangoglia, PT, DPT

Advertisement

Articles by Nicole Zangoglia, PT, DPT

Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval

ByPhilip J. Mease, MD,Nicole Zangoglia, PT, DPT,Andrew Sharobeem, DO, FACR
December 30th 2025

New advances in fibromyalgia are part of a larger shift in pain management in 2025.

Exploring Physical Therapy’s Role in Fibromyalgia Care, With Nicole Zangoglia, PT, DPT

Exploring Physical Therapy’s Role in Fibromyalgia Care, With Nicole Zangoglia, PT, DPT

ByNicole Zangoglia, PT, DPT
September 22nd 2025

Zangoglia shared advantages physical therapies may offer in treating people with fibromyalgia.

Advertisement

Latest Updated Articles

  • Exploring Physical Therapy’s Role in Fibromyalgia Care, With Nicole Zangoglia, PT, DPT
    Exploring Physical Therapy’s Role in Fibromyalgia Care, With Nicole Zangoglia, PT, DPT

    September 22nd 2025

  • Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
    Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval

    December 30th 2025



Advertisement
Advertisement

Trending on Rheumatology Live

1

Nipocalimab, Telitacicept, and the Sjögren’s Disease Pipeline

2

Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD

3

Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD

4

INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH

5

Selecting Sjögren’s Patients for Ianalumab and Weighing Safety

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
Rheumatology Live
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
News
Contact Us